Now Available On Demand 

Randomized, controlled clinical trials (RCTs) are the FDA-preferred approach for registrational studies in new drug and biologics development. However, there are circumstances in oncology where a single-arm trial can expedite the development of new treatments for oncology indications, reduce time to product approval and patient access, and demonstrate clinical benefit of novel product(s) on fewer patients. 

Join Veristat experts during a live webinar as they discuss single-arm oncology registrational studies, success stories and lessons learned in:

  • Identifying unmet medical needs that may allow for a single-arm registrational study
  • Developing a single-arm study design for registration
  • Determining a regulatory strategy
Watch Now

Meet the Speakers

Robin Bliss, PhD

Vice President, Strategic Consulting, Veristat

Debora Manning, MPH

Strategic Consulting Fellow, Biostatistician, Veristat

Toni Marie Nearing, BS

Principal Regulatory Strategist, Veristat

Register now for an inside look at single-arm oncology registrational studies and what it takes to successfully steer them through development and regulatory.

Register now to download the On-Demand!

By ticking this box, you agree to receive emails such as relevant news, updates and offers from Informa Business Intelligence, and carefully selected similar products from our portfolio
By completing this form you agree Pharma Intelligence and Veristat LLC may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Pharma Intelligence and Veristat LLC